Table 2. Equivalence of doses of inhaled corticosteroids licensed for use in Brazil.^a.

ADULTS AND ADOLESCENTS (≥ 12 years of age)
Corticosteroids	Type of inhaler	Low dose, µg/dayb	Medium dose, µg/day	High dose, µg/dayc
Beclomethasone dipropionate	DPI, HFA	100-200	> 200-400	> 400
Budesonide	DPI, HFA	200-400	> 400-800	> 800
Fluticasone propionate	DPI, HFA	100-250	> 250-500	> 500
Fluticasone Furoate	DPI	na	100	200
Mometasone Furoate	DPI	110-220	> 220-440	> 440
CHILDREN 6-11 YEARS OF AGE
Corticosteroids	Type of inhaler	Low dose, µg/dayb	Medium dose, µg/day	High dose, µg/dayc
Beclomethasone dipropionate	DPI, HFA	50-100	> 100-200	> 200
Budesonide	DPI	100-200	> 200-500	> 500
	Vials	250-500	> 500-1,000	> 1,000
Fluticasone propionate	HFA	100-200	> 200-500	> 500
	DPI	100-200	> 200-400	> 400
Mometasone Furoate	DPI	110	≥ 220 < 440	≥ 440
CHILDREN < 6 YEARS OF AGE
Corticosteroids	Type of inhaler	Low dose, µg/day	Age
Beclomethasone dipropionate	HFA	100	≥ 5 years
Budesonide	Vial	500	≥ 6 months
Fluticasone propionate	HFA	50	≥ 4 years
Mometasone Furoate	DPI	110	≥ 4 years

DPI: dry powder inhaler; HFA: hydrofluoroalkane, pressurized inhaler; and na: not available. ^aDose labeled on the medication box. ^bStandard dose to start and maintain the treatment of most patients. ^{2 , 9 ) c}Greatly increases the frequency and intensity of systemic adverse effects.